Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Mycobacterium bovis BCG Hsp65 Monoclonal Antibody

Cat. No.VD11Y589

Product TypeVeterinary Antibodies

Size

Product Overview

BioVenic mouse anti-Mycobacterium bovis BCG Hsp65 monoclonal antibody can be used in WB to help researchers detect or develop diagnosis assays of Mycobacterium bovis infection.

Specifications

Application WB
Clonality Monoclonal Antibody
Classification Primary Antibody
Clone N29Y21
Host Mouse
Target Species Bacteria
Species Reactivity Bacteria
Specificity Mycobacterium bovis BCG Hsp65
Isotype IgG
Immunogen Recombinant Mycobacterium bovis BCG Hsp65.
Purification Protein G purified
Conjugation Unconjugated
Preservative and Stabilizer 0.09% Sodium azide (NaN3), 50% Glycerol
Physical State Liquid

Target Information

Heat shock protein 65 (Hsp65) of Mycobacterium bovis BCG (Bacillus Calmette-Guérin) is a key immunogenic protein and it is a molecular chaperone that helps in the proper folding of proteins. Hsp65 has been studied as a diagnostic antigen for tuberculosis. Detection of antibodies or cellular responses to Hsp65 has been explored in serological and cellular assays for the diagnosis of tuberculosis.

Target Mycobacterium bovis BCG Hsp65
Target Synonym Chaperonin GroEL 2; 60 kDa chaperonin 2; 65 kDa antigen; Antigen A; Cell wall protein A; Chaperonin-60 2; (Cpn60 2); Heat shock protein 65
Gene ID 1091466
UniProt ID P0A521

Shipping and Storage

This product is shipped with dry ice. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Before use, centrifuge briefly in a tabletop centrifuge to remove any liquid from the container lid.

References

  1. Gonçalves, Eduardo DC, et al. "Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming." Genetic Vaccines and Therapy 5 (2007): 1-14.
Inquiry Basket